145 related articles for article (PubMed ID: 26505328)
1. PET Imaging of Steroid Hormone Receptor Expression.
Allott L; Smith G; Aboagye EO; Carroll L
Mol Imaging; 2015; 14(10):534-50. PubMed ID: 26505328
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of steroid receptor expression in breast and prostate cancer.
Hospers GA; Helmond FA; de Vries EG; Dierckx RA; de Vries EF
Curr Pharm Des; 2008; 14(28):3020-32. PubMed ID: 18991716
[TBL] [Abstract][Full Text] [Related]
3. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
4. The impact of transcription on metabolism in prostate and breast cancers.
Poulose N; Mills IG; Steele RE
Endocr Relat Cancer; 2018 Sep; 25(9):R435-R452. PubMed ID: 29760165
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor and microRNA regulation in cancer.
Tessel MA; Krett NL; Rosen ST
Curr Opin Oncol; 2010 Nov; 22(6):592-7. PubMed ID: 20739888
[TBL] [Abstract][Full Text] [Related]
6. The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.
Capper CP; Rae JM; Auchus RJ
Horm Cancer; 2016 Jun; 7(3):149-64. PubMed ID: 26969590
[TBL] [Abstract][Full Text] [Related]
7. Steroid enzyme and receptor expression and regulations in breast tumor samples - A statistical evaluation of public data.
Li T; Zhang W; Lin SX
J Steroid Biochem Mol Biol; 2020 Feb; 196():105494. PubMed ID: 31610224
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Gemignani ML; Patil S; Seshan VE; Sampson M; Humm JL; Lewis JS; Brogi E; Larson SM; Morrow M; Pandit-Taskar N
J Nucl Med; 2013 Oct; 54(10):1697-702. PubMed ID: 23970364
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
Aggarwal R; Wei X; Kim W; Small EJ; Ryan CJ; Carroll P; Cooperberg M; Evans MJ; Hope T
Eur Urol Oncol; 2018 May; 1(1):78-82. PubMed ID: 31100231
[TBL] [Abstract][Full Text] [Related]
10. Regulation of nuclear receptor and cofactor expression in breast cancer cell lines.
Vienonen A; Miettinen S; Manninen T; Altucci L; Wilhelm E; Ylikomi T
Eur J Endocrinol; 2003 Apr; 148(4):469-79. PubMed ID: 12656669
[TBL] [Abstract][Full Text] [Related]
11. Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers.
Cheng M; Michalski S; Kommagani R
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154312
[TBL] [Abstract][Full Text] [Related]
12. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract][Full Text] [Related]
15. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
[TBL] [Abstract][Full Text] [Related]
17. Nuclear hormone receptor co-repressors.
Baniahmad A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):89-97. PubMed ID: 15860250
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Palaskas N; Larson SM; Schultz N; Komisopoulou E; Wong J; Rohle D; Campos C; Yannuzzi N; Osborne JR; Linkov I; Kastenhuber ER; Taschereau R; Plaisier SB; Tran C; Heguy A; Wu H; Sander C; Phelps ME; Brennan C; Port E; Huse JT; Graeber TG; Mellinghoff IK
Cancer Res; 2011 Aug; 71(15):5164-74. PubMed ID: 21646475
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.
Stephen RL; Gustafsson MC; Jarvis M; Tatoud R; Marshall BR; Knight D; Ehrenborg E; Harris AL; Wolf CR; Palmer CN
Cancer Res; 2004 May; 64(9):3162-70. PubMed ID: 15126355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]